Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Chia Siang Kow; Syed Tabish Razi Zaidi; Syed Shahzad Hasan

doi:10.1007/s40256-020-00406-0

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Chia Siang Kow, Syed Tabish Razi Zaidi, Syed Shahzad Hasan

Research output: Contribution to journal › Review article › peer-review

23 Citations (Scopus)

Abstract

There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.

Original language	English
Pages (from-to)	217-221
Number of pages	5
Journal	American Journal of Cardiovascular Drugs
Volume	20
Issue number	3
Early online date	13 Apr 2020
DOIs	https://doi.org/10.1007/s40256-020-00406-0
Publication status	Published - 1 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s40256-020-00406-0Licence: Unspecified

Cite this

@article{c0e1d13cb6954408841d8f1f33ea678e,

title = "Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19",

abstract = "There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.",

keywords = "Cardiovascular Disease, Renin‑Angiotensin System Inhibitors, COVID-19",

author = "Kow, \{Chia Siang\} and Zaidi, \{Syed Tabish Razi\} and Hasan, \{Syed Shahzad\}",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s40256-020-00406-0",

language = "English",

volume = "20",

pages = "217--221",

journal = "American Journal of Cardiovascular Drugs",

issn = "1175-3277",

publisher = "Adis",

number = "3",

}

TY - JOUR

T1 - Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

AU - Kow, Chia Siang

AU - Zaidi, Syed Tabish Razi

AU - Hasan, Syed Shahzad

PY - 2020/6/1

Y1 - 2020/6/1

N2 - There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.

AB - There is ongoing debate on the safety of renin-angiotensin system (RAS) inhibitors in COVID-19. Recently published studies highlight a potential relationship between cardiovascular disease (CVD) and COVID-19. This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.

KW - Cardiovascular Disease

KW - Renin‑Angiotensin System Inhibitors

KW - COVID-19

UR - https://www.scopus.com/pages/publications/85083419313

U2 - 10.1007/s40256-020-00406-0

DO - 10.1007/s40256-020-00406-0

M3 - Review article

C2 - 32281055

SN - 1175-3277

VL - 20

SP - 217

EP - 221

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

IS - 3

ER -

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?

Study says inhalers OK to use amid COVID-19 concerns

Cite this

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Research output

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?

Press/Media

Study says inhalers OK to use amid COVID-19 concerns

Cite this